Coronary artery bypass grafting vs percutaneous coronary intervention in a 'real-world' setting: A comparative effectiveness study based on propensity score-matched cohorts

European Journal of Cardio-thoracic Surgery

Volumn 44, Issue 1, 2013, Pages

  Fortuna, Daniela ^a   Nicolini, Francesco ^b   Guastaroba, Paolo ^a   De Palma, Rossana ^a   Di Bartolomeo, Stefano ^a   Saia, Francesco ^c,d   Pacini, Davide ^c   Grilli, Roberto ^a   Passerini, F ^d   Vignali, L ^d   Manari, A ^d   Magnavacchi, P ^d   Rossi, R ^d   Benassi, A ^d   Sangiorgio, P ^d   Marzocchi, A ^d   Valgimigli, M ^d   Percoco, G ^d   Varani, E ^d   Cremonesi, A ^d   Tarantino, F ^d   Piovaccari, G ^d   more..

^a Regional Agency for Health and Social Care   (Italy)

^b UNIVERSITY OF PARMA   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d NONE

Author keywords

Cardiac surgery; Coronary artery bypass grafting; Percutaneous coronary angioplasty

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; PACLITAXEL; RAPAMYCIN;

ADULT; AGED; ARTICLE; BARE METAL STENT; CARDIAC PATIENT; CARDIOVASCULAR MORTALITY; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; COMPARATIVE EFFECTIVENESS; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DRUG ELUTING STENT; EXTRACORPOREAL CIRCULATION; FEMALE; FOLLOW UP; HEALTH CARE QUALITY; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; INTERMETHOD COMPARISON; LEFT CORONARY ARTERY; LOADING DRUG DOSE; MALE; OFF PUMP CORONARY SURGERY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PREVALENCE; PRIORITY JOURNAL; PROPENSITY SCORE; RISK ASSESSMENT; SURVIVAL RATE; TREATMENT DURATION;

EID: 84879577009     PISSN: 10107940     EISSN: 1873734X     Source Type: Journal    
DOI: 10.1093/ejcts/ezt197     Document Type: Article

References (25)

1. Molina JA, Heng BH. Global trends in cardiology and cardiothoracic surgery-an opportunity or a threat? Ann Acad Med 2009;38:541-45.
2. Park DW, Kim YH, Song HG, Song HG, Ahn JM, Lee JY et al. Long-term comparison of drug-eluting stents and coronary artery bypass grafting for multivessel coronary revascularization: 5-year outcomes from the Asian Medical Center-Multivessel Revascularization Registry. J Am Coll Cardiol 2011;57:128-37.
3. Park DW, Yun SC, Lee SW, Kim YH, Lee CW, Hong MK et al. Long-term mortality after percutaneous coronary intervention with drug eluting stent implantation versus coronary artery bypass surgery for the treatment of multivessel coronary artery disease. Circulation 2008;117: 2079-86.
4. Lee MS, Yang T, Dhoot J, Iqbal Z, Liao H. Meta-analysis of studies comparing coronary artery bypass grafting with drug-eluting stenting in patients with diabetes mellitus and multivessel coronary artery disease. Am J Cardiol 2010;105:1540-4.
5. Hannan EL, Wu C, Walford G, Culliford AT, Gold JP, Smith CR et al. Drug-eluting stents vs. coronary-artery bypass grafting in multivessel coronary disease. N Engl J Med 2008;358:331-41.
6. Li Y, Zheng Z, Xu B, Zhang S, Li W, Gao R et al. Comparison of drug-eluting stents and coronary artery bypass surgery for the treatment of multivessel coronary disease: three-year follow-up results from a single institution. Circulation 2009;119:2040-50.
7. Javaid A, Steinberg DH, Buch AN, Corso PJ, Boyce SW, Pinto Slottow TL et al. Outcomes of coronary artery bypass grafting versus percutaneous coronary intervention with drug-eluting stents for patients with multivessel coronary artery disease. Circulation 2007;116:I-200-6.
8. Rodriguez A, Bernardi V, Navia J, Baldi J, Grinfeld L, Martinez J et al. Argentine randomized study: coronary angioplasty with stenting versus coronary bypass surgery in patients with multiple vessel disease (ERACI II): 30-day and 1 year follow-up results. J Am Coll Cardiol 2001;37:51-8. (Erratum, J Am Coll Cardiol. 2001;37:973-974).
9. Serruys PW, Unger F, Sousa JE, Jatene A, Bonnier HJ, Schönberger JP et al. Arterial Revascularization Therapies Study Group. Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease. N Engl J Med 2001;344:1117-24.
10. Booth J, Clayton T, Pepper J, Nugara F, Flather M, Sigwart U et al. SoS Investigators. Randomized, controlled trial of coronary artery bypass surgery versus percutaneous coronary intervention in patients with multivessel coronary artery disease: six-year follow-up from the Stent or Surgery Trial (SoS). Circulation 2008;118:381-8.
11. Kappetein AP, Feldman TE, Mack MJ, Morice MC, Holmes DR, Ståhle E et al. Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or three vessel disease: 3-year followup of the SYNTAX trial. Eur Heart J 2011;32:2125-34.
12. Marzocchi A, Saia F, Piovaccari G, Manari A, Aurier E, Benassi A et al. Long-term safety and efficacy of drug-eluting stents: two-year results of the REAL (REgistro AngiopLastiche dell'Emilia Romagna) multicenter registry. Circulation 2007;115:3181-8.
13. Di Eusanio M, Fortuna D, De Palma R, Dell'Amore A, Lamarra M, Contini GA et al. Aortic valve replacement: results and predictors of mortality from a contemporary series of 2256 patients. J Thorac Cardiovasc Surg 2011;141:940-7.
14. Rosenbaum PR, Rubin DB. Reducing bias in observational studies using sub classification on the propensity score. J Am Stat Assoc 1984;79: 516-24.
15. Ho DE, Imai K, King G, Stuart EA. Matching as nonparametric preprocessing for reducing model dependence in parametric causal inference. Polit Anal 2007;15:199-236.
16. Austin PC, Grootendorst P, Anderson GM. A comparison of the ability of different propensity score models to balance measures of treatment effect: a Monte Carlo study. Stat Med 2007;26:734-53.
17. Normand ST, Landrum MB, Guadagnoli E, Ayanian JZ, Ryan TJ, Cleary PD et al. Validating recommendations for coronary angiography following acute myocardial infarction in the elderly: a matched analysis using propensity scores. J Clin Epidemiol 2001;54:387-98.
18. Klein JP, Moeschberger ML. Survival analysis: techniques for censored and truncated data. New York, NY: Springer-Verlag 1997.
19. Pepe MS, Mori M. Kaplan-Meier, marginal or conditional probability curves in summarizing competing risks failure time data? Stat Med 1993; 12:737-51.
20. Fine JP, Gray RJ. A proportional hazards model for the sub distribution of a competing risk. J Am Stat Assoc 1999;94:496-509.
21. Hueb W, Lopes N, Gersh BJ, Soares PR, Ribeiro EE, Pereira AC et al. Ten-year follow-up survival of the medicine, angioplasty, or surgery study (MASS II). A randomized controlled trial of 3 therapeutic strategies for multivessel coronary artery disease. Circulation 2010;122:949-57.
22. Serruys PW, Morice MC, Kappetein AP, Colombo A, Holmes DR, Mack MJ et al. SYNTAX Investigators. Percutaneous coronary interventions versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med 2009;360:961-72.
23. Mohr FW, Rastan AJ, Serruys PW, Kappetein AP, Holmes DR, Pomar JL et al. Complex coronary anatomy in coronary artery bypass graft surgery: impact of complex coronary anatomy in modern bypass surgery? Lessons learned from the SYNTAX trial after two years. J Thorac Cardiovasc Surg 2011;141:130-40.
24. Farkouh ME, Domanski M, Sleeper LA, Siami FS, Dangas G, Mack M et al. The FREEDOM Trial Investigators. Strategies for Multivessel Revascularization in Patients with Diabetes. N Engl J Med 2012;367: 2375-84.
25. Farkouh ME, Dangas G, Leon MB, Smith C, Nesto R, Buse JB et al. Design of the Future REvascularization Evaluation in patients with Diabetes mellitus: Optimal management of Multivessel disease (FREEDOM) trial. Am Heart J 2008;155:215-23.